Ub-RPS27A Activators
Ub-RPS27A activators comprise compounds that have the capability to either directly stimulate Ub-RPS27A's activity or indirectly affect its functionality through the modulation of associated cellular pathways. Particularly, many of these activators target the ubiquitin-proteasome system, a crucial cellular machinery for protein degradation. MG-132, Bortezomib, Epoxomicin, Lactacystin, and Velcade are proteasome inhibitors. By impeding the proteasome's action, these chemicals can enhance the accumulation of ubiquitinated proteins, which can then indirectly influence the activity and levels of Ub-RPS27A.
Additionally, compounds such as Chloroquine and NH4Cl act on lysosomal function, another pivotal component of protein degradation. Chloroquine is a lysosomotropic agent, increasing cellular ubiquitinated protein levels, whereas NH4Cl adjusts lysosomal pH, affecting protein degradation routes. Moreover, MLN4924, inhibiting the NEDD8-activating enzyme, provides a different approach to modulating the ubiquitin-proteasome system dynamics. By understanding the interconnected cellular pathways associated with Ub-RPS27A, these compounds provide insights into strategies for modulating this particular protein's functionality.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that can enhance the accumulation of ubiquitinated proteins, which may indirectly influence Ub-RPS27A. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Another proteasome inhibitor, it can also lead to the accumulation of ubiquitinated proteins, potentially affecting Ub-RPS27A. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
Inhibits NEDD8-activating enzyme, altering ubiquitin-proteasome system dynamics which can indirectly influence Ub-RPS27A. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Proteasome inhibitor that can influence the ubiquitin-proteasome system and indirectly modulate Ub-RPS27A activity. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
Inhibits autophagy, thereby modulating ubiquitination processes which may indirectly influence Ub-RPS27A. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
This compound inhibits vacuolar-type ATPase and can impact lysosomal degradation, potentially leading to an effect on Ub-RPS27A. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
A proteasome inhibitor, it can influence the ubiquitin-proteasome pathway, which may in turn affect Ub-RPS27A. | ||||||
Ammonium Chloride | 12125-02-9 | sc-202936 sc-202936A sc-202936B | 25 g 500 g 2.5 kg | $39.00 $55.00 $150.00 | 4 | |
By altering lysosomal pH, this compound can modulate protein degradation pathways, potentially influencing Ub-RPS27A indirectly. | ||||||